www.fdanews.com/articles/179793-fda-grants-marketing-clearance-to-cepheids-next-generation-test-for-mrsa-colonization
FDA Grants Marketing Clearance to Cepheid’s Next-Generation Test for MRSA Colonization
December 21, 2016
Sunnyvale, California-based Cepheid received clearance from the FDA for Xpert MRSA NxG methicillin-resistant Staphylococcus aureus (MRSA) infection control test.
Xpert MRSA NxG is a molecular test that delivers results in about an hour.
The test has been validated for use with both ESwab (Copan) and rayon swabs. — Cynthia Jessup